Your browser doesn't support javascript.
loading
Asian Thoracic Oncology Research Group (ATORG) Expert Consensus Statement on MET Alterations in NSCLC: Diagnostic and Therapeutic Considerations.
Ahn, Myung-Ju; Mendoza, Marvin Jonne L; Pavlakis, Nick; Kato, Terufumi; Soo, Ross A; Kim, Dong-Wan; Liam, Chong Kin; Hsia, Te-Chun; Lee, Chee Khoon; Reungwetwattana, Thanyanan; Geater, Sarayut; Chan, Oscar Siu Hong; Prasongsook, Naiyarat; Solomon, Benjamin J; Nguyen, Thi Thai Hoa; Kozuki, Toshiyuki; Yang, James Chih-Hsin; Wu, Yi-Long; Mok, Tony Shu Kam; Tan, Daniel Shao-Weng; Yatabe, Yasushi.
Afiliación
  • Ahn MJ; Division of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Mendoza MJL; Section of Medical Oncology, St. Luke's Medical Center - Global City, Philippines.
  • Pavlakis N; Department of Medical Oncology, Royal North Shore Hospital, University of Sydney, Sydney, NSW, Australia.
  • Kato T; Department of Thoracic Oncology, Kanagawa Cancer Center, Yokohama, Japan.
  • Soo RA; Department of Haematology-Oncology, National University Cancer Institute Singapore, Singapore.
  • Kim DW; Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Hospital, Seoul, Republic of Korea.
  • Liam CK; Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
  • Hsia TC; Department of Respiratory Therapy, China Medical University, Taichung, Taiwan; Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.
  • Lee CK; National Health and Medical Research Council Clinical Trials Centre, The University of Sydney, Sydney, NSW, Australia.
  • Reungwetwattana T; Division of Medical Oncology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
  • Geater S; Division of Internal Medicine, Faculty of Medicine, Songklanagarind Hospital, Prince of Songkla University, Songkhla, Thailand.
  • Chan OSH; Department of Clinical Oncology, Hong Kong Integrated Oncology Centre, Hong Kong SAR, China.
  • Prasongsook N; Division of Medical Oncology, Department of Medicine, Phramongkutklao Hospital, Bangkok, Thailand.
  • Solomon BJ; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Nguyen TTH; Department of Medical Oncology, National Cancer Hospital, Hanoi, Vietnam.
  • Kozuki T; Department of Thoracic Oncology and Medicine, National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime, Japan.
  • Yang JC; Department of Medical Oncology, National Taiwan University Cancer Center and National Taiwan University Hospital, Taipei, Taiwan.
  • Wu YL; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Mok TSK; Department of Clinical Oncology, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Tan DS; Division of Medical Oncology, National Cancer Centre Singapore, Singapore. Electronic address: daniel.tan.s.w@singhealth.com.sg.
  • Yatabe Y; Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan.
Clin Lung Cancer ; 23(8): 670-685, 2022 12.
Article en En | MEDLINE | ID: mdl-36151006
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Transición Epitelial-Mesenquimal / Neoplasias Pulmonares Tipo de estudio: Diagnostic_studies / Guideline Límite: Humans Idioma: En Revista: Clin Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Transición Epitelial-Mesenquimal / Neoplasias Pulmonares Tipo de estudio: Diagnostic_studies / Guideline Límite: Humans Idioma: En Revista: Clin Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos